{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:55:05Z","timestamp":1792709705120,"version":"4.5.0"},"reference-count":48,"publisher":"The Journal of Rheumatology","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>The effect of systemic sclerosis (SSc) on bone density is not well understood. Through systematic review of the literature, the objectives of this study were to synthesize data about the prevalence of low bone mineral density (BMD), risk factors for low BMD, and occurrence of fracture and fracture-related mortality in SSc.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>A search was conducted of MEDLINE (1948\u20132012), Evidence Based Medicine Reviews (1991\u20132012), EMBASE (1980\u20132012), and CINAHL (1981\u20132012). Abstracts were screened to identify studies that evaluated low BMD in patients with SSc. Two investigators independently used a standardized form to abstract prevalence of osteopenia and osteoporosis (OP); risk factors for low BMD, BMD measurements, frequency of fracture, and fracture-related mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Screening of 1032 citations identified 19 articles. Fifteen studies compared patients with SSc to controls. Most patients were white, female (prevalence 74%\u2013100%), and postmenopausal (prevalence 45.9%\u2013100%). The prevalence of low BMD and OP was 27%\u201353.3% and 3%\u201351.1%, respectively. Ten studies reported a lower BMD in patients with SSc compared to matched controls, whereas 2 studies reported no difference. Candidate risk factors for low BMD in SSc include family history of OP, age, menopause, diffuse subtype, presence of internal organ involvement, low vitamin D levels, and calcinosis. However, the studies supporting these factors were conflicting. Fracture rate ranged between 0% and 38%. No study reported OP-related fracture mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>The data suggest that patients with SSc are at risk of low BMD and fracture, especially when other risk factors for OP are present. The interaction of SSc manifestations, traditional OP risk factors, and clinically relevant outcomes is complex and warrants further research.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.130032","type":"journal-article","created":{"date-parts":[[2013,9,16]],"date-time":"2013-09-16T00:14:23Z","timestamp":1379290463000},"page":"1881-1890","source":"Crossref","is-referenced-by-count":71,"title":["Low Bone Density in Systemic Sclerosis. A Systematic Review"],"prefix":"10.3899","volume":"40","author":[{"given":"Mohammed A.","family":"Omair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pagnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"McDonald-Blumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2013,9,15]]},"reference":[{"key":"2018112909320804000_40.11.1881.1","doi-asserted-by":"publisher","DOI":"10.1007\/s100670050039"},{"key":"2018112909320804000_40.11.1881.2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.41.2.147"},{"key":"2018112909320804000_40.11.1881.3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.12.1117"},{"key":"2018112909320804000_40.11.1881.4","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100361"},{"key":"2018112909320804000_40.11.1881.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62349-5"},{"key":"2018112909320804000_40.11.1881.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2004.08.006"},{"key":"2018112909320804000_40.11.1881.7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-06-0591"},{"key":"2018112909320804000_40.11.1881.8","doi-asserted-by":"publisher","DOI":"10.1007\/BF02231519"},{"key":"2018112909320804000_40.11.1881.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-0999-2"},{"key":"2018112909320804000_40.11.1881.10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-6-200809160-00007"},{"key":"2018112909320804000_40.11.1881.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321"},{"key":"2018112909320804000_40.11.1881.12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9220","article-title":"A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis","volume":"9","author":"Stevenson","year":"2005","journal-title":"Health Technol Assess"},{"key":"2018112909320804000_40.11.1881.13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken485"},{"key":"2018112909320804000_40.11.1881.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.02.002"},{"key":"2018112909320804000_40.11.1881.15","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081287"},{"key":"2018112909320804000_40.11.1881.16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091143"},{"key":"2018112909320804000_40.11.1881.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.08.005"},{"key":"2018112909320804000_40.11.1881.18","doi-asserted-by":"publisher","DOI":"10.1007\/BF02208027"},{"key":"2018112909320804000_40.11.1881.19","first-page":"797","article-title":"Evidence for bone resorption in systemic sclerosis","volume":"22","author":"La Montagna","year":"1995","journal-title":"J Rheumatol"},{"key":"2018112909320804000_40.11.1881.20","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.011064"},{"key":"2018112909320804000_40.11.1881.21","first-page":"313","article-title":"Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis","volume":"22","author":"Frediani","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909320804000_40.11.1881.22","first-page":"1822","article-title":"Osteoporosis\u2014less than expected in patients with scleroderma?","volume":"27","author":"Neumann","year":"2000","journal-title":"J Rheumatol"},{"key":"2018112909320804000_40.11.1881.23","first-page":"61","article-title":"Bone density and HLA antigens in patients with progressive systemic sclerosis","volume":"96","author":"D\u2019Amore","year":"2005","journal-title":"Minerva Med"},{"key":"2018112909320804000_40.11.1881.24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.4.371"},{"key":"2018112909320804000_40.11.1881.25","doi-asserted-by":"publisher","DOI":"10.1007\/BF02207673"},{"key":"2018112909320804000_40.11.1881.26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1590\/S0104-42301997000100010","article-title":"Estudo da densidade \u00f3ssea em esclerodermia sist\u00eamica [Portuguese]. Study of bone density in systemic scleroderma","volume":"43","author":"da Silva","year":"1997","journal-title":"Rev Assoc Med Bras"},{"key":"2018112909320804000_40.11.1881.27","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080192"},{"key":"2018112909320804000_40.11.1881.28","first-page":"180","article-title":"Prognostic factors of low bone mineral density in systemic sclerosis","volume":"23","author":"Sampaio-Barros","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909320804000_40.11.1881.29","doi-asserted-by":"publisher","DOI":"10.1080\/03009740600704296"},{"key":"2018112909320804000_40.11.1881.30","first-page":"1073","article-title":"Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions","volume":"35","author":"Yuen","year":"2008","journal-title":"J Rheumatol"},{"key":"2018112909320804000_40.11.1881.31","first-page":"125","article-title":"The evaluation of bone mineral density and risk factors of osteoporosis in patients with diffuse connective tissue diseases","volume":"8","author":"Zurek","year":"2003","journal-title":"Osteologicky Bulletin"},{"key":"2018112909320804000_40.11.1881.32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2340\/0001555563235237","article-title":"Bone mineral content in systemic sclerosis measured by photonabsorptiometry","volume":"63","author":"Serup","year":"1983","journal-title":"Acta Derm Venereol"},{"key":"2018112909320804000_40.11.1881.33","first-page":"153","article-title":"Bone mineral density in systemic sclerosis","volume":"40","author":"Sampaio-Barros","year":"2000","journal-title":"Rev Bras Rheumatol"},{"key":"2018112909320804000_40.11.1881.34","first-page":"535","article-title":"Bein\u00fe\u00e9ttni og umsetning \u00ed herslismein [Icelandic]. Bone mineral density and bone turnover in systemic sclerosis","volume":"93","author":"Alexandersson","year":"2007","journal-title":"Laeknabladid"},{"key":"2018112909320804000_40.11.1881.35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2340\/0001555563447449","article-title":"Does long-term treatment with D-penicillamine alter calcium and phosphorus metabolism in patients with systemic sclerosis?","volume":"63","author":"Hagdrup","year":"1983","journal-title":"Acta Derm Venereol"},{"key":"2018112909320804000_40.11.1881.36","first-page":"68","article-title":"Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis","volume":"30","author":"Allanore","year":"2003","journal-title":"J Rheumatol"},{"key":"2018112909320804000_40.11.1881.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91049-9"},{"key":"2018112909320804000_40.11.1881.38","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20568"},{"key":"2018112909320804000_40.11.1881.39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.33549\/physiolres.930307","article-title":"Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism","volume":"52","author":"Zofkova","year":"2003","journal-title":"Physiological Res"},{"key":"2018112909320804000_40.11.1881.40","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080340"},{"key":"2018112909320804000_40.11.1881.41","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100363"},{"key":"2018112909320804000_40.11.1881.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2009.01.373"},{"key":"2018112909320804000_40.11.1881.43","first-page":"188","article-title":"Fracture risk tool validation in an integrated healthcare delivery system","volume":"17","author":"Lo","year":"2011","journal-title":"Am J Manag Care"},{"key":"2018112909320804000_40.11.1881.44","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.100771"},{"key":"2018112909320804000_40.11.1881.45","first-page":"639","article-title":"How meaningful is our evaluation of meaningful change in osteoarthritis?","volume":"33","author":"Hawker","year":"2006","journal-title":"J Rheumatol"},{"key":"2018112909320804000_40.11.1881.46","first-page":"1584","article-title":"Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension","volume":"35","author":"Johnson","year":"2008","journal-title":"J Rheumatol"},{"key":"2018112909320804000_40.11.1881.47","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006193704132"},{"key":"2018112909320804000_40.11.1881.48","unstructured":"Omair MA McDonald-Blumer H Johnson SR . Bone disease in systemic sclerosis: outcomes and associations. Clin Exp Rheumatol 2014. In press."}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.130032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:14:03Z","timestamp":1715984043000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.130032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,15]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,1]]},"published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.3899\/jrheum.130032"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.130032","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,15]]}}}